Gritstone Jumps Into COVID-19 Vaccine Race, Eyeing Mutant Strains
Potentially Resistant Strains Raise Worries
The company is developing a vaccine with both adenoviral and mRNA technology that could potentially overcome resistance mutations on the SARS-CoV-2 spike protein.
